NCT06011941

Brief Summary

The modified laparoscopic transcystic biliary drainage which we developed in the treatment of cholecystocholedocholithiasis has some advantages over conventional techniques. Here, a 7-Fr triple-lumen 30-cm central venous catheter was adopted to replace conventional 5-Fr ureteral catheter, which extended the function of the C-tube. Then we developed a continued suture and circling manner by the V-Loc closure device, which simultaneously covered and anchored the C-tube. Theoretically, this modified laparoscopic transcystic drainage not only provide safe and effective bile duct drainage, but also provide a convenient access of treatment for postoperatively retained bile duct stones, which may expand the indication of initially laparoscopic operation in the management of cholecysto-choledocholithiasis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2024Jul 2027

First Submitted

Initial submission to the registry

August 22, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

3 years

First QC Date

August 22, 2023

Last Update Submit

August 22, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • postoperative overall morbidity

    All outcome variables will be assessed according to internationally accepted standards if available, that is, the consensus definitions for surgical and medical complications according to the Clavien-Dindo classification.

    6 months

  • bile leakage

    Bile leakage is determined according to the definition and grading of severity by the International Study Group of Liver Surgery.

    6 months

Secondary Outcomes (3)

  • anchoring time of the C-tube

    6 months

  • average daily drainage volume

    6 months

  • early dislodgement of C-tube

    6 months

Study Arms (1)

modified laparoscopic transcystic biliary drainage

EXPERIMENTAL

A 7-Fr triple-lumen 30-cm central venous catheter was adopted to replace conventional 5-Fr ureteral catheter. Then we developed a continued suture and circling manner by the V-Loc closure device, which simultaneously covered and anchored the C-tube. Furthermore, the catheter was introduced through the abdominal wall located at 3 cm below the costal margin on the midaxillary line/the posterior axillary line, which was traditionally performed at the point below the midclavicular line on the right side.

Procedure: Modified laparoscopic transcystic biliary drainage

Interventions

First, a needle was passed through a separate skin puncture wound 3 cm below the costal margin on the midaxillary line/posterior axillary line. Second, a lateral incision into the cystic duct was performed medially to allow insertion and embedding of the catheter. Third, a 7-Fr catheter was introduced through the abdominal wall via the cystic duct into the CBD. Fourth, if the position of the catheter inside the CBD was correct (the end of the tube reached the distal CBD but did not pass the papilla), the lateral incision of the cystic duct was closed by a V-Loc closure device using a single-layered, continuous suture in a circling manner to simultaneously cover and anchor the C-tube. After the procedure, an artificial fistula of 3 to 5 mm in length was formed.

modified laparoscopic transcystic biliary drainage

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years of age;
  • Patients with gallbladder stones and known or expected concomitant bile duct stones;
  • Informed consent.

You may not qualify if:

  • Biliary drainage is already present, e.g. preoperative ENBD, PTCD;
  • Women who are pregnant;
  • Declined consent;
  • Inability to follow the procedures of the study, e.g. due to language problems and psychological disorders of the participant;
  • Morbid obesity (BMI \> 40);
  • IV-VI class of the American Society of Anesthesiologists physical status classification;
  • Contraindications for general anesthesia or surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lingfu Zhang

Beijing, None Selected, 100191, China

Location

Related Publications (2)

  • Zhang LF, Hou CS, Xu Z, Wang LX, Ling XF, Wang G, Cui L, Xiu DR. [Clinical effect of laparoscopic transcystic drainage combined with common bile duct exploration for the patients with difficult biliary stones]. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1185-1189. doi: 10.19723/j.issn.1671-167X.2022.06.021. Chinese.

    PMID: 36533353BACKGROUND
  • Zhang YY, Wang G, Hou C, Xu Z, Wang L, Cui L, Ling X, Zhang L. Safety and effectiveness of modified laparoscopic transcystic biliary drainage in the treatment of choledocholithiasis: study protocol for a prospective single-arm clinical trial. BMJ Open. 2025 Apr 23;15(4):e089540. doi: 10.1136/bmjopen-2024-089540.

MeSH Terms

Conditions

GallstonesCholecystitisCholedocholithiasis

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCommon Bile Duct DiseasesBile Duct Diseases

Study Officials

  • LINGFU ZHANG

    北京大学第三医院

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2023

First Posted

August 25, 2023

Study Start

January 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

August 25, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations